Hillan K, Nordlinger B, Ballet F, Puts J P, Infante R
INSERM Liver Research Unit 9, Hopital Saint Antoine, Paris, France.
J Surg Res. 1988 Feb;44(2):166-71. doi: 10.1016/0022-4804(88)90045-5.
Early postoperative intraperitoneal administration of 5-fluorouracil (5-Fu) is a logical adjuvant treatment of patients with resectable colonic cancers. It is easier and less invasive than the intraportal administration of the drug. However, before applying the procedure to humans it must be demonstrated than it does not disturb the healing of recent colonic anastomoses. Colonic sutures were performed in 78 male Wistar rats. The animals then either served as controls or received intraperitoneal 5-Fu during 5 days starting on the first, third, or seventh postoperative day. No statistical difference was observed between treated and control groups when observing the incidence of anastomotic spontaneous disruptures, anastomotic healing strength, or the weight of the animals. It is concluded that early intraperitoneal 5-Fu administration does not impair the healing of recent colonic anastomoses in rats.
术后早期腹腔内给予5-氟尿嘧啶(5-Fu)是可切除结肠癌患者合理的辅助治疗方法。它比门静脉给药更容易且侵入性更小。然而,在将该方法应用于人体之前,必须证明它不会干扰近期结肠吻合口的愈合。对78只雄性Wistar大鼠进行结肠缝合。然后,这些动物要么作为对照组,要么在术后第一天、第三天或第七天开始的5天内接受腹腔内5-Fu治疗。在观察吻合口自发性破裂的发生率、吻合口愈合强度或动物体重时,治疗组和对照组之间未观察到统计学差异。结论是早期腹腔内给予5-Fu不会损害大鼠近期结肠吻合口的愈合。